Medial EalrySign develops AI-based clinical decision-support and population health solutions. We focus on the early prediction of clinical outcomes related to cancers, metabolic, immune and infectious diseases by applying machine learning algorithms on basic medical information, such as blood test results, medications and other EMR data. Our goal is to make these insights accessible by all stakeholders including healthcare organizations, doctors, and eventually patients
